| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Pathology,* University of Pittsburgh Medical Center, Pittsburgh; Department of Pharmacology, University of Pittsburgh School of Medicine; and University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, Pennsylvania
MicroRNAs are small noncoding 18- to 24-nt RNAs that are predicted to regulate expression of as many as 30% of protein-encoding genes. In prostate adenocarcinoma, 39 microRNAs are up-regulated, and six microRNAs are down-regulated. Production and function of microRNA requires coordinated processing by proteins of the microRNA machinery. Dicer, an RNase III endonuclease, is an essential component of the microRNA machinery. From a gene array analysis of 16 normal prostate tissue samples, 64 organ-confined, and four metastatic prostate adenocarcinomas, we identified an up-regulation of major components of the microRNA machinery, including Dicer, in metastatic prostate adenocarcinoma. Immunohistochemical studies on a tissue microarray consisting of 232 prostate specimens confirmed up-regulation of Dicer in prostatic intraepithelial neoplasia and in 81% of prostate adenocarcinoma. The increased Dicer level in prostate adenocarcinoma correlated with clinical stage, lymph node status, and Gleason score. Western blot analysis of benign and neoplastic prostate cell lines further confirmed Dicer up-regulation in prostate adenocarcinoma. Dicer up-regulation may explain an almost global increase of microRNA expression in prostate adenocarcinoma. The presence of up-regulated microRNA machinery may predict the susceptibility of prostate adenocarcinoma to RNA interference-based therapy.
This article has been cited by other articles:
 |
|
 |
|
  W.-X. Wang, B. R. Wilfred, Y. Hu, A. J. Stromberg, and P. T. Nelson Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes RNA, February 1, 2010; 16(2): 394 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W.F. Catto, S. Miah, H. C. Owen, H. Bryant, K. Myers, E. Dudziec, S. Larre, M. Milo, I. Rehman, D. J. Rosario, et al. Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer Cancer Res., November 1, 2009; 69(21): 8472 - 8481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sotiropoulou, G. Pampalakis, E. Lianidou, and Z. Mourelatos Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell RNA, August 1, 2009; 15(8): 1443 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ueda, G. Kohanbash, K. Sasaki, M. Fujita, X. Zhu, E. R. Kastenhuber, H. A. McDonald, D. M. Potter, R. L. Hamilton, M. T. Lotze, et al. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1 PNAS, June 30, 2009; 106(26): 10746 - 10751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kuruma, Y. Kamata, H. Takahashi, K. Igarashi, T. Kimura, K. Miki, J. Miki, H. Sasaki, N. Hayashi, and S. Egawa Staphylococcal Nuclease Domain-Containing Protein 1 as a Potential Tissue Marker for Prostate Cancer Am. J. Pathol., June 1, 2009; 174(6): 2044 - 2050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Merritt, Y. G. Lin, L. Y. Han, A. A. Kamat, W. A. Spannuth, R. Schmandt, D. Urbauer, L. A. Pennacchio, J.-F. Cheng, A. M. Nick, et al. Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer N. Engl. J. Med., December 18, 2008; 359(25): 2641 - 2650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Horikawa, C. G. Wood, H. Yang, H. Zhao, Y. Ye, J. Gu, J. Lin, T. Habuchi, and X. Wu Single Nucleotide Polymorphisms of microRNA Machinery Genes Modify the Risk of Renal Cell Carcinoma Clin. Cancer Res., December 1, 2008; 14(23): 7956 - 7962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Asada, T. Takahashi, K. Isodono, A. Adachi, H. Imoto, T. Ogata, T. Ueyama, H. Matsubara, and H. Oh Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2512 - H2521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, S. A. Perdreau, P. Chatterjee, L. Wang, S.-F. Kuan, and A. Duensing Imatinib Mesylate Induces Quiescence in Gastrointestinal Stromal Tumor Cells through the CDH1-SKP2-p27Kip1 Signaling Axis Cancer Res., November 1, 2008; 68(21): 9015 - 9023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.J. D. Ho and P. A. Marsden Dicer Cuts the Kidney J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2043 - 2046. [Full Text] [PDF]
|
|
|
|
|
|
S. Ambs, R. L. Prueitt, M. Yi, R. S. Hudson, T. M. Howe, F. Petrocca, T. A. Wallace, C.-G. Liu, S. Volinia, G. A. Calin, et al. Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer Cancer Res., August 1, 2008; 68(15): 6162 - 6170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, S. Volinia, T. Bonome, G. A. Calin, J. Greshock, N. Yang, C.-G. Liu, A. Giannakakis, P. Alexiou, K. Hasegawa, et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer PNAS, May 13, 2008; 105(19): 7004 - 7009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Porkka, M. J. Pfeiffer, K. K. Waltering, R. L. Vessella, T. L.J. Tammela, and T. Visakorpi MicroRNA Expression Profiling in Prostate Cancer Cancer Res., July 1, 2007; 67(13): 6130 - 6135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Blenkiron and E. A. Miska miRNAs in cancer: approaches, aetiology, diagnostics and therapy Hum. Mol. Genet., April 15, 2007; 16(R1): R106 - R113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chiosea, E. Jelezcova, U. Chandran, J. Luo, G. Mantha, R. W. Sobol, and S. Dacic Overexpression of Dicer in Precursor Lesions of Lung Adenocarcinoma Cancer Res., March 1, 2007; 67(5): 2345 - 2350. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
